Free Trial Free TrialFree Trial

More results...

Filter by Content types
Market profile databases
Regulatory databases
Regulatory reports
Market reports
Market Snapshots
Infographics
News analysis
Pricing snapshots
Brand price trackers
Flavour trackers
Filter by Geography
Africa
Asia
Australasia
Central America
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Canada Canadian Tobacco and Nicotine Survey 2022 results published…
  • United Kingdom Government concerned over disposable vape environmental impact…
  • Czech Republic EC notified of planned e-cig tax labels…
  • Lithuania Anti-smuggling bill postponed to await WHO evaluation…
  • Lithuania Proposal to restrict e-cig sales to pharmacies clarified…
  • United Kingdom Seizures of non-compliant and illegal vape products continue…
  • France Anses updates list of e-cig notifications…
  • Sweden List of e-cig notifications updated…
  • Italy ADM updates list of notified e-cigs…
  • United States CTP seeks nominations for a new science committee member…
  • United Kingdom Questions raised over impact of potential disposables ban…
  • Czech Republic Call to combat addiction with proportional regulation, not bans…
View all
News analysis

Senators urge rejection of PMI reduced risk application after TPSAC findings

Written by || 13th February 2018 || News analysis || Health and science | Policy and Politics | Regulation and Legislation | North America United States

Ten US Senators have urged the FDA to reject PMI's reduced risk application for IQOS following the findings of the independent Tobacco Products Scientific Advisory Committee (TPSAC) ...

Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us

Related contents
Could the TPD allow for reduced-risk claims?
FDA committee rejects two IQOS MRTP claims, approves one
Has Reuters’ IQOS investigation crucially dented PMI’s reputation?

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


    See more


    By signing up you agree to our Privacy Policy.